Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Abstract
Objective: To assess the effectiveness of resistin in predicting the severity of acute pancreatitis.
Methods: Patients with acute pancreatitis who presented at the Gastroenterology Clinic,
Erzurum Education and Research Hospital, Turkey were enrolled in this prospective study. White
blood cell (WBC), C-reactive protein (CRP) and resistin levels were measured on admission and at
24 h, day 3 and day 7 following admission, along with other blood parameters. Patients were
divided into two groups: mild acute pancreatitis and moderate/severe acute pancreatitis.
Results: Of 59 patients with acute pancreatitis (mild, n 37; moderate/severe, n 22), significant
between-group differences were found in terms of resistin and CRP levels. Receiver operating
curve analysis showed that resistin levels were better for predicting severe cases of acute
pancreatitis than CRP or WBC levels on day 3 (area under the curve [AUC], 0.88 versus 0.81 and
0.63, respectively). Resistin levels on day 3 were better than CRP levels for predicting necrosis
development (AUC, 0.70 versus 0.69, respectively).
Conclusions: Resistin may represent a new, effective indicator to predict the severity of acute
pancreatitis and presence of necrosis in patients with acute pancreatitis.
Keywords
Resistin, acute pancreatitis, predictive factor, C-reactive protein (CRP)
Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial
3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and
distribution of the work without further permission provided
Downloaded the original work
from imr.sagepub.com is attributed
by guest on March as specified on the SAGE and Open Access page
7, 2016
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
2 Journal of International Medical Research 0(0)
Rating systems and serum markers are who presented to the Gastroenterology
used in conjunction with clinical, laboratory Clinic of Erzurum Education and Research
and radiological ndings in order to predict Hospital, Erzurum, Turkey, between
the severity of clinical progression in cases of November 2012 and December 2013.
acute pancreatitis.46 One acute-phase react- Patients whose diagnoses were veried
ant, C-reactive protein (CRP), is a com- through clinic and laboratory ndings, and
monly used marker for distinguishing who met the criteria for study inclusion,
between a mild and severe acute pancreatitis were sequentially enrolled.
attack. Damage to the pancreas in acute Inclusion criteria for the study com-
pancreatitis and the intensity of the organ- prised the presence of clinical ndings,
ism response (i.e., the acute-phase response) typical history, body mass index (BMI)
is accompanied by a substantial increase in between 20 and 25, a more than three-fold
the serum CRP level, which is the most increase in serum amylase and lipase
signicant reactant in this response, as a values, and verication of the monitoring
result of hepatocyte stimulation by cyto- methods. Exclusion criteria included iron
kines. In acute inammation, CRP levels deciency anaemia, renal failure, liver dis-
often reach their peak at 48 h.7,8 ease, chronic pancreatitis, a second or later
Improved knowledge of the roles of pancreatitis attack, symptoms lasting >3
cytokines has increased understanding of days prior to admission, and a diagnosis
the pathogenesis of acute pancreatitis. that was not veried through monitoring
White adipose tissue is a multifunctional methods.
organ that releases protein signals and fac- Upper abdominal ultrasonography was
tors such as leptin, adiponectin, resistin, conducted on admission, and computed
ghrelin and apelin on a vast scale.9 tomography (CT) was performed on day 4
Changes in the function and quantity of or 5 following admission. Biochemical par-
these proteins plays a role in the pathogen- ameters were assessed using two dierent
esis and progress of inammation, inam- blood samples taken within the rst 2 h
matory response, insulin resistance and following presentation and at a time
metabolic syndrome.10 Resistin is a newly between the rst 2 and 72 h, based on
identied peptide hormone, secreted specif- when the patient was admitted to hospital.
ically by adipocytes,11 that can cause obesity Each patients age, sex and reason for
and hypertriglyceridaemia, due to its asso- hospital admission were recorded.
ciation with insulin resistance.12,13 Studies Each patient was evaluated by monitor-
have revealed that resistin is also an import- ing with the Balthazar CT rating system and
ant cytokine in inammatory reactions, and CT severity index, and pancreatic necrosis
in the regulation of other cytokines.1416 assessment. The patients were divided into
The aim of the present study was to assess two groups based on the Atlanta classica-
the eectiveness of resistin in predicting the tion.17 The rst group included patients
severity of acute pancreatitis, and to com- without complications (mild acute pancrea-
pare resistin with CRP in predicting the titis); the second group included patients
severity of acute pancreatitis. with one or several organ failures (moderate
or severe acute pancreatitis).
Patients and methods Approval for the study was obtained
from the Ethical Committee of Erzurum
Study population Regional Education and Research Hospital.
This prospective observational study All patients participating in the study pro-
included patients with acute pancreatitis vided written informed consent.
Table 1. Demographic, laboratory and clinical characteristics of patients with mild and moderate or severe
acute pancreatitis.
Study group
Moderate or
Mild acute severe acute Statistical
Characteristic pancreatitis n 37 pancreatitis n 22 significance
signicantly dierent (P < 0.001, P 0.001, signicantly lower in the mild acute pan-
and P 0.029 respectively). Strongly signi- creatitis patient group (8.5 4.4 days) com-
cant between-group dierences were also pared with the moderate/severe patient
found in terms of resistin levels (day 1 [24 h], group (16.3 7.7 days, P < 0.001). A signi-
day 3 and day 7) and CRP levels (day 1 cant between-group dierence was also
[24 h], day 3 and day 7; Table 1), with lower found in terms of Balthazar score and CT
levels in the mild acute pancreatitis groups severity index (1[04] versus 3.6 [34],
versus moderate/severe acute pancreatitis P < 0.001 and 0.9 [04] versus 5.6 [310],
group. Duration of hospital stay was P < 0.001, respectively).
Table 2. Correlation between resistin and C-reactive protein (CRP) levels or white blood cell (WBC)
counts in patients with acute pancreatitis.
A strong correlation was observed have decreased, but the death rate due to
between resistin and CRP, and resistin and infected necrosis and septic complications in
WBC in the rst 24 h, day 3 and day 7 the latter period remains relatively high.2
(Table 2). In patients with mild acute pan- C-reactive protein is an easily detectable
creatitis, resistin levels remained relatively marker that is frequently used to predict the
stable during the 7-day study period, clinical severity of acute pancreatitis, necro-
whereas in the moderate or severe acute sis and mortality. CRP is able to dierenti-
pancreatitis group, resistin levels gradually ate between mild and severe acute
increased. pancreatitis with high precision, and to
The ROC analysis (applied to predict predict the development of severe acute
cases of severe acute pancreatitis) showed pancreatitis even at 24 h following hospital
that the predictive value was signicantly admission.2022 However, very few studies
higher for resistin levels than for CRP and have examined the power of CRP for pre-
WBC levels on day 3 (AUC, 0.88, 0.81 and dicting pancreatic necrosis.23 Patients with
0.63, respectively; Figure 1). Resistin levels CRP levels > 150 mg/l on admission to the
on day 3 were also revealed to be signi- emergency unit and on transfer to the
cantly better than CRP levels in predicting intensive care unit have been shown to
necrosis development (AUC, 0.70 and 0.69, have signicantly and independently worse
respectively; Figure 2). The cut-o value was outcomes that those with lower CRP
determined to be 19.5 ng/ml (93% sensitiv- levels.24 Although there is a 2448-h latency
ity, 70% specicity) for severe pancreatitis period before CRP levels increase, which
limits its utility as an early predictor of
severity, CRP remains a useful predictor
Discussion when levels have risen.20,23,24
Acute pancreatitis is a frequently seen dis- The main problem in managing acute
ease with a wide clinical spectrum ranging pancreatitis is the lack of availability of
from mild to severe. Most acute pancreatitis convenient indicators or scoring systems for
progresses mildly and is self-limiting, how- predicting severity and necrosis in the rst
ever, 1020% of the cases progress severely hours of the disease, although many indica-
and 2943% of severe cases progress tors have been researched in this
fatally.2,3,18,19 Mortality rates associated regard.1,48,1924 The adipokine family,
with systemic inammatory responses in which contains adiponectin, leptin, resistin
the earlier periods of severe pancreatitis and visfatin, may help to resolve this
Figure 1. Receiver operating curve analysis of resistin, CRP and WBC levels on day 3 following hospital
admission for predicting severe acute pancreatitis (AP) in patients with mild or moderate/severe acute
pancreatitis. CRP, C-reactive protein; WBC, white blood cell count.
problem. Resistin and visfatin are hormones pancreatitis.30,31 Resistin may be a causative
that are synthesized in neutrophils, macro- factor of obesity and hypertriglyceridemia,
phages, bone marrow, and fat tissue and can due to its association with insulin
increase proinammatory cytokine resistance.13,30
release.16,25,26 A relationship between acute pancreatitis
Adipose tissue is thought to be part of the and adipokines was shown by a study
endocrine system, and to play a role in the reporting signicantly higher serum leptin
pathogenesis of acute pancreatitis. levels in patients with acute pancreatitis and
Peripancreatic adipose tissue necrosis can an animal model of acute pancreatitis,
lead to intense cytokine release (interleukin compared with control groups.32 A study
[IL]-1, IL-6, tumour necrosis factor-a) and that investigated resistin levels in the pan-
adipokines can play a role in multiorgan creatic tissue of rats with acute pancreatitis
failure and systemic changes.27,28 The early revealed a correlation between the resistin
increase in adipocyte-induced indicators can level and disease-related tissue damage,30
be an important predictor of the clinical and also showed that the CRP level was
progress of acute pancreatitis.29 Obesity is associated with disease severity.30 Another
considered an independent risk factor for study revealed that resistin levels were sig-
the development of severe acute nicantly higher in patients with acute
Figure 2. Receiver operating curve analysis of resistin, CRP and WBC levels on day 3 following hospital
admission for predicting necrosis development in patients with mild or moderate/severe acute pancreatitis.
CRP, C-reactive protein; WBC, white blood cell count.
pancreatitis compared with heathy con- day 3 following admission, compared with
trols.33 Prompted by these published studies, controls. Resistin levels were increased on
the present study further investigated the day 5 compared with day 3, and a signicant
relationship between resistin levels and the correlation was found between the CRP and
severity of acute pancreatitis. resistin levels.35
In one study,34 signicantly elevated In the present study, resistin levels were
admission resistin levels was shown in signicantly dierent between patients with
patients with higher pancreatic and extra- mild acute pancreatitis and those with mod-
pancreatic necrosis scores, and a resistin cut- erate or severe acute pancreatitis at admis-
o value of 11.9 ng/ml was found in the sion and on days 1, 3 and 7 following
presence of peripancreatic necrosis. These admission. Likewise, in patients with mild
results34 suggest that there is a signicant acute pancreatitis, resistin levels remained
correlation between resistin levels and sever- relatively stable during the 7-day study
ity of disease, intervention requirements, period, whereas in the moderate/severe
morbidity and mortality; such ndings con- acute pancreatitis group, resistin levels grad-
curred with another acute pancreatitis ually increased. The present study revealed
study,35 in which resistin levels were signi- that day 3 resistin levels provided improved
cantly higher at hospital admission, and on prediction for severe pancreatitis compared
13. Steppan CM, Bailey ST, Bhat S, et al. The 24. Makela JT, Eila H, Kiviniemi H, et al.
hormone resistin links obesity to diabetes. Computed tomography severity index and
Nature 2001; 409: 307312. C-reactive protein values predicting mortal-
14. Hsu CL, Lin YJ, Ho CT, et al. The inhibitory ity in emergency and intensive care units for
effect of pterostilbene on inflammatory patients with severe acute pancreatitis. Am J
responses during the interaction of 3T3-L1 Surg 2007; 194: 3034.
adipocytes and RAW 264.7 macrophages. 25. Moschen AR, Kaser A, Enrich B, et al.
J Agric Food Chem 2013; 61: 602610. Visfatin, an adipocytokine with proinflam-
15. Minn AH, Patterson NB, Pack S, et al. matory and immunomodulating properties.
Resistin is expressed in pancreatic islets. J Immunol 2007; 178: 17481758.
Biochem Biophys Res Commun 2003; 310: 26. Silswal N, Singh AK, Aruna B, et al. Human
641645. resistin stimulates the proinflammatory
16. Bokarewa M, Nagaev I, Dahlberg L, et al. cytokines TNF-alpha and IL-12 in macro-
Resistin, an adipokine with potent proin- phages by NF-kappaB-dependent pathway.
flammatory properties. J Immunol 2005; 174: Biochem Biophys Res Commun 2005; 334:
57895795. 10921101.
17. Banks PA, Bollen TL, Dervenis C, et al. 27. Karpavicius A, Dambrauskas Z, Sileikis A,
Classification of acute pancreatitis2012: et al. Value of adipokines in predicting the
revision of the Atlanta classification and severity of acute pancreatitis:
definitions by international consensus. Gut Comprehensive review. World J
2013; 62: 102111. Gastroenterol 2012; 18: 66206627.
18. Appelros S and Borgstrom A. Incidence, 28. Ouchi N, Parker JL, Lugus JJ, et al.
aetiology and mortality rate of acute pan- Adipokines in inflammation and metabolic
creatitis over 10 years in a defined urban disease. Nat Rev Immunol 2011; 11: 8597.
population in Sweden. Br J Surg 1999; 86: 29. Schaffler A and Scholmerich J. The role of
465470. adiponectin in inflammatory gastrointestinal
19. Harrison DA, DAmico G and Singer M. diseases. Gut 2009; 58: 317322.
The Pancreatitis Outcome Prediction (POP) 30. Xue LN, Wang XY, Tan Y, et al.
score: a new prognostic index for patients Significance of resistin expression in acute
with severe acute pancreatitis. Crit Care Med pancreatitis. Exp Ther Med 2015; 9:
2007; 35: 17031708. 14381442.
20. Pongprasobchai S, Jianjaroonwong V, 31. Sempere L, Martinez J, de Madaria E, et al.
Charatcharoenwitthaya P, et al. Erythrocyte Obesity and fat distribution imply a greater
sedimentation rate and C-reactive protein
systemic inflammatory response and a worse
for the prediction of severity of acute pan-
prognosis in acute pancreatitis.
creatitis. Pancreas 2010; 39: 12261230.
Pancreatology 2008; 8: 257264.
21. Mayer AD, McMahon MJ, Bowen M, et al.
32. Konturek PC, Jaworek J, Maniatoglou A,
C reactive protein: an aid to assessment and
et al. Leptin modulates the inflammatory
monitoring of acute pancreatitis. J Clin
response in acute pancreatitis. Digestion
Pathol 1984; 37: 207211.
2002; 65: 149160.
22. Gurleyik G, Emir S, Kilicoglu G, et al.
33. Lesniowski B, Kumor A, Jasinska A, et al.
Computed tomography severity index,
Resistin a new laboratory marker useful in
APACHE II score, and serum CRP concen-
diagnosis of acute pancreatitis? Pol Merkur
tration for predicting the severity of acute
Lekarski 2007; 22: 385387. [in Polish,
pancreatitis. JOP 2005; 6: 562567.
English abstract].
23. Mason JM, Babu BI, Bagul A, et al. The
34. Schaffler A, Hamer O, Dickopf J, et al.
performance of organ dysfunction scores for
Admission resistin levels predict peripan-
the early prediction and management of
creatic necrosis and clinical severity in acute
severity in acute pancreatitis: an exploratory
phase diagnostic study. Pancreas 2010; 39: pancreatitis. Am J Gastroenterol 2010; 105:
11041108. 24742484.
35. Daniel P, Lesniowski B, Mokrowiecka A, 36. Mart nez J, Johnson CD, Sanchez-Paya J,
et al. Circulating levels of visfatin, resistin et al. Obesity is a definitive risk factor of
and pro-inflammatory cytokine interleukin-8 severity and mortality in acute pancreatitis:
in acute pancreatitis. Pancreatology 2010; 10: an updated meta-analysis. Pancreatology
477482. 2006; 6: 206209.